Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib Safety Study in Indian Women with Advanced Breast Cancer
NCT04707196Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abemaciclib in breast cancer, sponsored by Eli Lilly and Company. Started Feb 2021; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04707196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707196.